{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T13:40:26Z","timestamp":1774878026470,"version":"3.50.1"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,4,1]]},"DOI":"10.1093\/ndt\/gfi272","type":"journal-article","created":{"date-parts":[[2005,11,16]],"date-time":"2005-11-16T02:58:42Z","timestamp":1132109922000},"page":"1131-1132","source":"Crossref","is-referenced-by-count":4,"title":["Rho\/Rho-kinase and C-reactive protein relationship in hypertension and atherosclerosis"],"prefix":"10.1093","volume":"21","author":[{"given":"Lorenzo A.","family":"Cal\u00f2","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Pagnin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Mussap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Semplicini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,11,15]]},"reference":[{"key":"key\n\t\t\t\t20171011044926_BIB1","doi-asserted-by":"crossref","unstructured":"Masumoto A, Hirooka Y, Shimokawa H, Hironaga K, Setoguchi S, Takeshita A. Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans. Hypertension2001; 38: 1307\u20131310","DOI":"10.1161\/hy1201.096541"},{"key":"key\n\t\t\t\t20171011044926_BIB2","doi-asserted-by":"crossref","unstructured":"Wettschureck N, Offermanns S. Rho\/Rho-kinase mediated signaling in physiology and pathophysiology. J Mol Med2002; 80: 629\u2013638","DOI":"10.1007\/s00109-002-0370-2"},{"key":"key\n\t\t\t\t20171011044926_BIB3","doi-asserted-by":"crossref","unstructured":"Higashi M, Hiroki J, Hattori T et al. Long-term inhibition of Rhokinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system. Circ Res2003; 93: 767\u2013775","DOI":"10.1161\/01.RES.0000096650.91688.28"},{"key":"key\n\t\t\t\t20171011044926_BIB4","doi-asserted-by":"crossref","unstructured":"Takemoto M, Sun J, Hiroki J, Shimokawa H, Liao JK. Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase. Circulation2002; 106: 57\u201362","DOI":"10.1161\/01.CIR.0000020682.73694.AB"},{"key":"key\n\t\t\t\t20171011044926_BIB5","doi-asserted-by":"crossref","unstructured":"Takeda K, Ichiki T, Tokunou T et al. Critical role of Rho-kinase and MEK-ERK pathways for angiotensin II-induced plasminogen activator inhibitor type-1 gene expression. Arterioscler Thromb Vasc Biol2001; 21: 868\u2013873","DOI":"10.1161\/01.ATV.21.5.868"},{"key":"key\n\t\t\t\t20171011044926_BIB6","doi-asserted-by":"crossref","unstructured":"Eto Y, Shimokawa H, Hiroki J et al. Gene transfer of dominant negative Rho kinase suppresses neointimal formation after balloon injury in pigs. Am J Physiol2000; 278: H1744\u2013H1750","DOI":"10.1152\/ajpheart.2000.278.6.H1744"},{"key":"key\n\t\t\t\t20171011044926_BIB7","doi-asserted-by":"crossref","unstructured":"Wolfrum S, Dendorfer A, Rikitake Y et al. Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3 kinase\/protein kinase Akt and cardiovascular protection. Arterioscler Thromb Vasc Biol2004; 24: 1842\u20131847","DOI":"10.1161\/01.ATV.0000142813.33538.82"},{"key":"key\n\t\t\t\t20171011044926_BIB8","doi-asserted-by":"crossref","unstructured":"Nakakuki T, Ito M, Iwasaki H et al. Rho\/Rho-kinase pathway contributes to C-reactive protein-induced plasminogen activator inhibitor-1 expression in endothelial cells. Arterioscler Thromb Vasc Biol2005; 25: 2088\u20132093","DOI":"10.1161\/01.ATV.0000183607.50230.9f"},{"key":"key\n\t\t\t\t20171011044926_BIB9","doi-asserted-by":"crossref","unstructured":"Cal\u00f2 L, Davis PA, Semplicini A. Regulation of vascular tone in Bartter's and Gitelman's syndromes. Crit Rev Clin Lab Sci2000; 37: 503\u2013523","DOI":"10.1080\/10408360091174295"},{"key":"key\n\t\t\t\t20171011044926_BIB10","doi-asserted-by":"crossref","unstructured":"Cal\u00f2 LA, Pessina AC, Semplicini A. Angiotensin II signaling in the Bartter's and Gitelman's syndromes, a negative human model of hypertension. High Blood Press Cardiovasc Prev2005; 12: 17\u201326","DOI":"10.2165\/00151642-200512010-00004"},{"key":"key\n\t\t\t\t20171011044926_BIB11","doi-asserted-by":"crossref","unstructured":"Pagnin E, Davis PA, Sartori M, Semplicini A, Pessina AC, Cal\u00f2 LA. Rho kinase and PAI-1 in Bartter's\/Gitelman's syndromes: relationship to angiotensin II signaling. J Hypertens2004; 22: 1963\u20131969","DOI":"10.1097\/00004872-200410000-00019"},{"key":"key\n\t\t\t\t20171011044926_BIB12","doi-asserted-by":"crossref","unstructured":"Pagnin E, Semplicini A, Sartori M, Pessina AC, Cal\u00f2 LA. Reduced mRNA and protein content of Rho guanine nucleotide exchange factor (RhoGEF) in Bartter's and Gitelman's syndromes. relevance for the pathophysiology of hypertension. Am J Hypertens2005; 18: 1200\u20131205","DOI":"10.1016\/j.amjhyper.2005.03.747"},{"key":"key\n\t\t\t\t20171011044926_BIB13","doi-asserted-by":"crossref","unstructured":"Cal\u00f2 L, Davis PA, Semplicini A. Bartter's\/Gitelman's syndrome: a model for the relationships between hypertension, angiotensin II, oxidative stress and remodeling. Clin Nephrol2003; 59: 393\u2013394","DOI":"10.5414\/CNP59393"},{"key":"key\n\t\t\t\t20171011044926_BIB14","doi-asserted-by":"crossref","unstructured":"Cal\u00f2 LA, Pagnin E, Davis PA et al. Increased expression of regulator of G protein signaling\u20132 (RGS-2) in Bartter's\/Gitelman's syndrome. A role in the control of vascular tone and implication for hypertension. J Clin Endocrinol Metab2004; 89: 4153\u20134157","DOI":"10.1210\/jc.2004-0498"},{"key":"key\n\t\t\t\t20171011044926_BIB15","doi-asserted-by":"crossref","unstructured":"Cal\u00f2 L, Ceolotto G, Milani M et al. Abnormalities of Gq-mediated cell signaling in Bartter and Gitelman syndromes. Kidney Int2001; 60: 882\u2013889","DOI":"10.1046\/j.1523-1755.2001.060003882.x"},{"key":"key\n\t\t\t\t20171011044926_BIB16","doi-asserted-by":"crossref","unstructured":"Cal\u00f2 L, Davis PA, Semplicini A. Reduced content of alpha subunit of Gq protein in monocytes of Bartter and Gitelman syndromes: relationship with vascular hyporeactivity. Kidney Int2002; 61: 353\u2013354","DOI":"10.1046\/j.1523-1755.2002.00128.x"},{"key":"key\n\t\t\t\t20171011044926_BIB17","doi-asserted-by":"crossref","unstructured":"Di Virgilio F, Cal\u00f2 L, Cantaro S, Favaro S, Piccoli A, Borsatti A. Resting and stimulated cytosolic free calcium levels in neutrophils from patients with Bartter's syndrome. Clin Sci1987; 72: 483\u2013488","DOI":"10.1042\/cs0720483"},{"key":"key\n\t\t\t\t20171011044926_BIB18","doi-asserted-by":"crossref","unstructured":"Calo L, D\u2019Angelo A, Cantaro S et al. Intracellular calcium signalling and vascular reactivity in Bartter's syndrome. Nephron1996; 72: 570\u2013573","DOI":"10.1159\/000188941"},{"key":"key\n\t\t\t\t20171011044926_BIB19","doi-asserted-by":"crossref","unstructured":"Cal\u00f2 LA, Pagnin E, Davis PA, Sartori M, Semplicini A. Oxidative stress related factors in Bartter's and Gitelman's syndromes: relevance for angiotensin II signalling. Nephrol Dial Transplant2003; 18: 1518\u20131525","DOI":"10.1093\/ndt\/gfg204"},{"key":"key\n\t\t\t\t20171011044926_BIB20","doi-asserted-by":"crossref","unstructured":"Cal\u00f2 L, Sartore G, Bassi A et al. Reduced susceptibility of low density lipoprotein to oxidation in patients with overproduction of nitric oxide (Bartter's and Gitelman's syndrome). J Hypertens1998; 16: 1001\u20131008","DOI":"10.1097\/00004872-199816070-00014"},{"key":"key\n\t\t\t\t20171011044926_BIB21","unstructured":"Cal\u00f2 L, Davis PA, Milani M et al. Increased endothelial nitric oxide synthase mRNA level in Bartter's and Gitelman's syndrome. Relationship to vascular reactivity. Clin Nephrol1999; 51: 12\u201317"},{"key":"key\n\t\t\t\t20171011044926_BIB22","doi-asserted-by":"crossref","unstructured":"Cal\u00f2 L, D\u2019Angelo A, Cantaro S et al. Increased urinary NO2\u2212\/NO3\u2212 and cyclic GMP levels in patients with Bartter's syndrome: relationship to vascular reactivity. Am J Kidney Dis1996; 27: 874\u2013879","DOI":"10.1016\/S0272-6386(96)90514-4"},{"key":"key\n\t\t\t\t20171011044926_BIB23","doi-asserted-by":"crossref","unstructured":"Mita S, Kobayashi N, Yoshida K, Nakano S, Matsuoka H. Cardioprotective mechanisms of Rho-kinase inhibition associated with eNOS and oxidative stress-LOX-1 pathway in Dahl salt-sensitive hypertensive rats. J Hypertens2005; 23: 87\u201396","DOI":"10.1097\/00004872-200501000-00017"},{"key":"key\n\t\t\t\t20171011044926_BIB24","doi-asserted-by":"crossref","unstructured":"Davis PA, Mussap M, Pagnin E, Bertipaglia L, Semplicini A, Cal\u00f2 LA. Early markers of inflammation in a high angiotensin II state. Results of studies in Bartter's\/Gitelman's syndromes. J Intern Med2005 submitted","DOI":"10.1093\/ndt\/gfl112"},{"key":"key\n\t\t\t\t20171011044926_BIB25","doi-asserted-by":"crossref","unstructured":"Perona R, Montaner S, Saniger L, Sanchez-Perez I, Bravo R, Lacal JC. Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins. Genes Dev1997; 11: 463\u2013475","DOI":"10.1101\/gad.11.4.463"},{"key":"key\n\t\t\t\t20171011044926_BIB26","doi-asserted-by":"crossref","unstructured":"Segain JP, Raingeard de la Bletiere D, Sauzeau V et al. Rho kinase blockade prevents inflammation via nuclear factor kappa B inhibition: evidence in Crohn's disease and experimental colitis. Gastroenterology2003; 124: 1180\u20131187","DOI":"10.1016\/S0016-5085(03)00283-X"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/21\/4\/1131\/12881246\/gfi272.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T23:51:38Z","timestamp":1586562698000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ndt\/article\/21\/4\/1131\/1931968\/RhoRhokinase-and-Creactive-protein-relationship-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,15]]},"references-count":26,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2005,11,15]]},"published-print":{"date-parts":[[2006,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfi272","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,4]]},"published":{"date-parts":[[2005,11,15]]}}}